98%
921
2 minutes
20
Background: Hepatitis C virus (HCV) genotype (GT) 1 is the most common HCV GT in Western and Central Europe. The main focus of this present work is to analyze the change of baseline characteristics of 17 093 HCV-patients with genotype 1a/1b with antiviral therapy in Germany between 2004 and 2018. We analyzed five periods: (i) 2004-2007, (ii) 2008-2010, (iii) 2010-2013, (iv) 2014-2016, (v) 2017-2018.
Methods: The present analysis is based on five German non-interventional registry studies and comprises data on 17 093 HCV-GT1 patients documented between 2004 and 2018 [ML17071, ML19464, ML21645, ML25724 (Peginterferon alfa-2a non-interventional study [PAN]) and the German Hepatitis C-Registry (DHC-R).
Findings: Overall, 7662 patients were infected with HCV GT1a and 9431 patients with HCV GT1b. GT1a patients were younger (46.5 years vs. 51.2 years) and more often male (70 % vs. 52 %). Previous or ongoing drug abuse was documented more frequently for GT1a patients throughout the study periods with highest frequencies in the most recent period (2017-2018; 44 % for GT1a and 10.3 % for GT1b). Metabolic comorbidities, such as those who are overweight and those with diabetes mellitus, were associated with HCV GT1b-infected women. The GT1a ratio increased from 33.6 % (2004-2007) to 50 % (2017-2018). A relevant change in the GT1a/1b ratio was observed over time in men (2004-2007: 38 %/63 %; 2017-2018: 59 %/41 %). In contrast, only 30 % of women had GT1a infection throughout all study periods without relevant changes. There were no regional differences within Germany in HCV GT1a/1b distribution despite a higher proportion of GT1b-infected women in East Germany in 2004-2007 (86 %).
Conclusion: A marked increase of GT1a infection associated with drug use was observed in men, but not women, in Germany between 2004 and 2018. The present data show a fundamental change in HCV epidemiology, which has an impact on therapy management and general care of hepatitis C patients in Germany.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/a-1332-2214 | DOI Listing |
Eur J Cancer
September 2025
Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Aim Of The Study: The aim of the study is to describe clinical features, treatment approach and outcomes of recurrent/metastatic (R/M) NPC in non-endemic areas MATERIALS AND METHODS: This observational, retrospective and multicenter study was conducted within 36 referral hospital in non-endemic areas including Europe, Jordan, Kuwait, Turkey and United States of America. All NPC patients diagnosed between 2004 and 2016 and with a minimum 12 months of follow-up were included. Data entry started in January 2018 and closed in December 2023.
View Article and Find Full Text PDFInt J Surg
September 2025
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Background: Cholangiocarcinomas have a poor prognosis, and resection is the only curative-intent treatment. We examined time-trends in mortality risk after resection in a nationwide Danish cohort.
Methods: We identified all Danish citizens diagnosed with cholangiocarcinoma in 2004-2022 who subsequently underwent liver resection, biliary tract resection, or a combination of the two.
J Infus Nurs
September 2025
Author Affiliations: Department of Nursing, Federal University of Rio Grande do Norte, Natal, Brazil (Lima, Sena, Bispo, Chagas, Ribeiro, and de Oliveira Araújo).
Objective: The aim of this study was to map nursing care in the treatment of lesions due to vasoactive drug extravasation. This scoping review is built according to the recommendations of the Joanna Briggs Institute and PRISMA-ScR.
Methods: The review was carried out from July to August 2022, across 12 data sources.
J Med Entomol
September 2025
Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.
The United States Centers for Disease Control and Prevention introduced the National Tick Surveillance Program in 2018 to better define areas of acarologic risk in response to the increasing burden of blacklegged tick (Ixodes scapularis, Acari: Ixodidae)-associated infections. The program coordinates surveillance efforts conducted by state and local public health programs and collates acarological data in the ArboNET Tick Module national database. Among the metrics collected, the density of infected host-seeking nymphs (DIN) is believed to be most closely correlated with the reported occurrence of tick-borne diseases.
View Article and Find Full Text PDFTrop Med Int Health
September 2025
Department of Population Science, Jatiya Kabi Kazi Nazrul Islam University, Mymensingh, Bangladesh.
Background: Ensuring a continuum of care in accessing antenatal to postnatal healthcare services is crucial for improving maternal and child health outcomes. This study aims to explore trends in the continuum of care over the years, both nationally and across regions; to provide district-level estimates; and to examine socio-economic disparities and determinants of continuum of care uptake in Bangladesh.
Methods: A total of 28,260 samples were analysed.